Scynexis launches public offering of Common Stock

Client(s) Scynexis, Inc.

Jones Day led a team that handled the IP diligence for a follow-on public offering of common stock for Scynexis, Inc., a Research Triangle Park, North Carolina, pharmaceutical company committed to the discovery, development, and commercialization of novel anti-infectives. The public offering resulted in the selling of approximately 5.4M shares of common stock at a public offering price of $7.70 per share, providing net proceeds of approximately $37.8M.